Avadel Pharmaceuticals (AVDL) Revenue Breakdown: Q3 2025 Business & Regional Performance
Avadel Pharmaceuticals (AVDL) reported total revenue of 77.47M USD in Q3 2025, with its core business segment Product contributing 100.00%. Regionally, United States remained the largest market, accounting for 97.96% of total revenue. Explore Avadel Pharmaceuticals's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.